CVN417 is an orally active antagonist of nAChR containing the alpha6 subunit, modulating phasic dopaminergic neurotransmission in an impulse-dependent fashion. It inhibits Ca(2+) efflux through nAChR subunits, displaying IC50 values of 0.086 µM (alpha6), 2.56 µM
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
